Showing results (491-500 of 498) with videos related to
Sort By:
Pageof 50
You have reached the last page of results.This site can display upto 498 results.
Cell|May 11, 2020
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United StatesJoseph R Fauver, Mary E Petrone, Emma B Hodcroft, et al.Nature|September 25, 2023
Distinguishing features of long COVID identified through immune profilingJon Klein, Jamie Wood, Jillian R Jaycox, et al.Plos Biology|May 7, 2021
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2Chantal B F Vogels, Mallery I Breban, Isabel M Ott, et al.Nature Microbiology|July 12, 2020
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe setsChantal B F Vogels, Anderson F Brito, Anne L Wyllie, et al.Medrxiv : the Preprint Server for Health Sciences|July 7, 2021
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 lineagesMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.Communications Biology|May 11, 2022
Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and IotaMary E Petrone, Jessica E Rothman, Mallery I Breban, et al.Frontiers in Immunology|October 19, 2017
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.Frontiers in Immunology|August 4, 2017
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin ContentKerry Dobbs, Giovanna Tabellini, Enrica Calzoni, et al.Pageof 50